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Edited by Varda RotterAbstract This study examined the role of Daxx in ischemic
stress. Upon ischemic stress, nuclear export of Daxx to the cyto-
plasm was observed in primary myocytes as well as in various cell
lines. Daxx silencing using siRNAs was detrimental in tethering
PML-nuclear body (PML-NB) constituents together. Overex-
pression of Daxx (W621A) caused nuclear export of p53 inde-
pendently of PML and promoted ischemic cell death via
activation of JNK. Conversely, overexpression of Daxx
(S667A) prevented dissociation of PML-NB constituents and
protected cells from ischemic death. Collectively, our results
demonstrate that the subcellular localization of Daxx determines
its role in ischemic cell death.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The death-associated protein, Daxx, is mainly known for its
death receptor adaptor role at the cell surface [1,2]. Daxx binds
to Fas and potentiates Fas-mediated apoptosis in the cyto-
plasm via the apoptosis signal-regulating kinase 1 (ASK1)ﬁ
c-Jun N-terminal kinase (JNK) pathway, independently of
the FADD/caspase-8 pathway [3–7]. Daxx also binds to the
transforming growth factor beta (TGFb) receptor to mediate
JNK activation [8]. According to immunohistochemical stud-
ies, however, Daxx is mainly observed in the nucleus [1,9],
where its nuclear-speckle distribution coincides with that of
promyelocytic leukemia protein-nuclear bodies (PML-NBs)
[10,11]. Recently, Daxx traﬃcking between subcellular com-
partments has been reported [12], which may explain the
apparently contradictory data regarding the subcellular local-
ization of Daxx.
Daxx shuttles between the nucleus and cytoplasm. The nu-
clear export of Daxx is induced by various stimuli such as glu-Abbreviations: ASK1, apoptosis signal-regulating kinase 1; CH, chem-
ical hypoxia; JNK, c-Jun N-terminal kinase; LMB, leptomycin B;
siRNA, small interference RNA; PML-NB, promyelocytic leukemia
protein-nuclear body; RASSF1C, Ras-associated domain family 1C
protein; scRNA, control scrambled siRNA
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15]. Daxx nuclear export depends on the phosphorylation sta-
tus of Ser-667 by the homeodomain-interacting protein kinase
1 (HIPK1) [15]. Conversely, interferon a/b stimulates Daxx
import in a tyrosine kinase 2 (Tyk2)-regulated manner
[16,17]. Nuclear Daxx can also be redistributed within subnu-
clear compartments. Daxx is present within PML-NBs, but
can also leave PML-NBs and move through the nucleoplasm
[18,19]. Time-dependent shuttling of Daxx between centro-
meres and PML-NBs during cell-cycle progression has been
reported [9,20–22]. Although the functional signiﬁcance of
these observations remains to be determined, Daxx might have
diﬀerent roles depending on its subcellular localization.
In the present study, we examined the role of Daxx in ische-
mic stress. To further understand the controversial roles of
Daxx, we used Daxx mutants that were conﬁned to speciﬁc
subcellular locations. We found that most Daxx is localized
to the nuclei of resting cells, where it co-localizes with PML
and p53. In response to ischemic stress, Daxx is exported to
the cytoplasm and ischemic cell death is mediated via JNK
activation. Our data indicate that Daxx is a scaﬀolding protein
and, is essential for the structural maintenance of PML-NBs.
Finally, our ﬁndings provide a possible solution to the contro-
versy surrounding the function of Daxx.2. Materials and methods
2.1. Cell culture and transient transfection
Rat embryonic heart-derived H9c2, rat skeletal muscle L6 and hu-
man cervical carcinoma HeLa cells were maintained in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) with 10% heat-inactivated fetal
bovine serum (FBS) and antibiotics (Gibco BRL). H9c2 cells were
transfected using the Nucleofector system (Amaxa). 1 · 106 cells were
suspended in 100 ll Nucleofector Solution Kit R (Amaxa) containing
2 lg of plasmid in a 2 mm electroporation cuvette. H9c2 cells were
transfected with the electrical setting T-20. Transfection into HeLa
was performed using Metafectene (Biontex Laboratories) according
to the manufacturer’s protocol. Primary rat neonatal cardiac myocyte
cultures were prepared from 1 to 2 day-old rats as described previously
[23].2.2. Experimental simulations of ischemia
In the case of chemical hypoxia (CH), cells were washed once with
phosphate-buﬀered saline (PBS) and placed in the metabolic inhibition
buﬀer (106 mM NaCl, 4.4 mM KCl, 1 mM MgCl2 Æ 6H2O, 38 mM
NaHCO3, 2.5 mM CaCl2, 20 mM 2-deoxy-D-glucose, 1 mM NaCN,
pH 6.6) for indicated time periods [24]. In the case of using an anaer-
obic chamber, cultures were incubated in serum-free, glucose-free
DMEM using an anaerobic chamber (Forma Scientiﬁc) at 37 C with
5% CO2, 10% H2 and 85% N2.blished by Elsevier B.V. All rights reserved.
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21-Nucleotide RNA oligonucleotides were synthesized from Qiagen
Inc. (Qiagen). The small interference RNA (siRNA) sequence for rat
Daxx (si-rDaxx) was chosen by referring to the previously reported hu-
man Daxx siRNA sequence [25,26]. The siRNAs used in this study
were si-rDaxx, 5 0-GGAGUUGGAUCUGUCAGAAdTdT-3 0 (sense),
5 0-UUCUGACAGAUCCAACUCCdTdT-3 0 (antisense); si-rPML,
5 0-CGUGUUCUUCGAGAGCCUGdTdT-3 0 (sense), 5 0-CAGGCU-
CUCGAAGAACACGdTdT-3 0 (antisense); si-rp53, 5 0-GCAUGAAC-
CGCCGGCCCAUdTdT-3 0 (sense), 5 0-AUGGGCCGGCGGUU-
CAUGCdTdT (antisense); and scrambled RNA (scRNA),
5 0-GCGCGCUUUGUAGGAUUCGdTdT-3 0 (sense), 5 0-CGAAUC-
CUACAAAGCGCGCdTdT-3 0 (antisense). The scRNA sequence rep-
resents a 21-nucleotide RNA oligonucleotide with no signiﬁcant
homology to any mammalian gene sequence and therefore serves as
a non-silencing control [27]. The sense and antisense siRNAs were an-
nealed according to manufacturer’s instructions.
2.4. cDNA constructs and mutagenesis
Daxx was subcloned into pFLAG-CMV-2. Daxx substitution mu-
tants, Daxx (W621A) and Daxx (S667A), were constructed with the
QuikChange site-directed mutagenesis kit as previously described [15].Fig. 1. Daxx nuclear export in response to ischemic injury. (a, b) Cultures of
2 h). The confocal microscopic images (a) and Western blot analysis (b) o
conditions for the indicated times (0, 1, 2, and 4 h). Cells were then incubated
was labeled with a ﬂuorescein-5-isothiocyanate (FITC)-conjugated anti-rab
iodide (PI). WB, Western blot.2.5. Immunoﬂuorescence microscopy
Cells grown on glass cover slips were ﬁxed in 4% paraformaldehyde/
PBS (pH 7.3) for 15 min at room temperature, permeabilized in 0.5%
Triton X-100 in PBS for 15 min at room temperature. The ﬁxed cells
were processed for immunoﬂuorescence. Polyclonal rabbit anti-Daxx,
goat anti-Daxx, and rabbit anti-p53 antibodies were purchased from
Santa Cruz biotechnology, and anti-SUMO1 monoclonal antibody
was purchased from Zymed Laboratories. Anti-PML monoclonal anti-
body 5E10 was a generous gift from Dr. R. van Driel (University of
Amsterdam, Amsterdam, Netherlands) [28]. Transfected H9c2 and
HeLa cells were plated on cover slips in culture medium for 12 h, cells
were incubated for the indicated times in metabolic inhibition buﬀer.
Cover slips were examined on a Zeiss LSM510 (Carl Zeiss) or a Bio-
Rad Radiance 2000 laser scanning confocal microscope (BioRad)
using 40· or 60· objective. Bars represent 10 lm in all micrographs.
2.6. DAPI DNA staining assay
Slightly modiﬁed DAPI staining was performed as described previ-
ously [29]. Cells were grown on cover slips in six well culture plates.
The ﬁxed cells were permeabilized with 0.5% Triton X-100 in PBS
for 15 min, followed by staining with 2 lg/ml of DAPI. Then the cells
were observed and counted under ﬂuorescence microscope.H9c2 cells were subjected to CH for the indicated times (0, 0.5, 1, and
f treated cells are shown. (c) H9c2 cells were subjected to anaerobic
with a rabbit polyclonal Daxx antibody. (a–c) Bound primary antibody
bit secondary antibody, and nuclei were visualized using propidium
Fig. 2. Traﬃcking of PML-NB constituents in response to ischemic stress. Immunoﬂuorescence microscopy was performed in H9c2 cells using
mouse anti-PML (5E10) (a), rabbit anti-p53 (b) and mouse anti-SUMO1 (c), together with the anti-Daxx antibody. a–c (ﬁrst columns): Red
represents PML (a), p53 (b), and SUMO1 (c). a–c (second columns): Green represents Daxx. a–c (third columns): The red and green images were
merged. (d) Rat L6 myoblast cells, before and after CH, were immunostained with anti-PML (5E10) and anti-Daxx antibodies. a–d (last columns): In
double-label colocalization experiment, control immunoﬂuorescence image is shown to exclude the possible artifact by double-label experiment. (e)
Primary rat neonatal cardiac myocytes were prepared as described in Section 2. Cells were then ﬁxed and assessed for the immunoﬂuorescence of
Daxx (green) and PML (red). (f) H9c2 cells were subjected to CH treatment for 1.5 h. Whole-cell lysates were then subjected to immunoprecipitation
using anti-PML monoclonal antibody 5E10. The blot was probed with anti-p53 monoclonal antibody (DO-1). The same membrane was stripped
and reprobed repeatedly with rabbit anti-Daxx and anti-PML (5E10) to detect Daxx and PML, respectively. IgG, immunoglobulin G; IP,
immunoprecipitation; WCL, whole-cell lysate.
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Fig. 2 (continued)
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Dead cells were determined by DNA content analysis using PI stain-
ing. For transient transfection studies, cells were cotransfected with the
green ﬂuorescent protein (GFP) expression vector pEGFP-C2, and the
proﬁles were determined for the GFP-gated cells. The transfected H9c2
cells were trypsinized, resuspended in 70% cold ethanol, ﬁxed over-
night at 20 C, washed twice with PBS, subjected to RNase (QIA-
GEN) digestion (1 mg/ml), and stained with PI (Sigma) for 30 min at
room temperature. The stained cells were analyzed by EPICS XL ﬂow
cytometer (Beckmann Coulter) by gating on an area versus width dot
plot to exclude debris and aggregates.2.8. JNK assay
The level of JNK phosphorylation was measured after CH with or
without SP600125 treatment (an inhibitor of JNK, TOCRIS). In vitro
kinase assays were performed as previously reported [30].2.9. Immunoprecipitation and Western analysis
To test for interactions among PML, Daxx and p53 in H9c2 cells,
cells were lysed in mammalian lysis buﬀer and immunoprecipitated
with anti-PML monoclonal antibody 5E10. Immunoprecipitates were
washed and separated by SDS–PAGE. The membrane was probed
with anti-PMLmonoclonal antibody 5E10, rabbit anti-Daxx antibody,
and anti-p53 monoclonal antibody (DO-1) followed by HRP-conju-
gated secondary antibodies (Santa Cruz). Proteins in the membranes
were then visualized using the enhanced ECL reagent (Amersham Bio-
sciences).2.10. Reporter assay
H9c2 cells were transfected with 2 lg of si-rDaxx, 1 lg of pFLAG-
CMV-2-p53 plasmid, 0.2 lg of CMV-b-galactosidase plasmid, and
0.2 lg of pG13-luciferase plasmid as indicated. pG13-luciferase plasmid
[31] was a generous gift fromDr. Hong-duk Youn (Seoul National Uni-
versity, Korea). Transfections were carried out usingNucleofector Solu-
tion Kit R (Amaxa) according to the manufacturer’s instructions.
Lysates were prepared and assayed for luciferase activities according
to the manufacturer’s instructions (Promega). Luciferase values were
normalized for transfection eﬃciency by measuring b-galactosidase
activity.3. Results
3.1. Ischemia induces nuclear export of Daxx
To simulate ischemic injury, we used 2-deoxy-D-glucose and
sodium cyanide to induce chemical hypoxia (CH) [24]. In rest-
ing H9c2 cells, Daxx was visible as distinct nuclear speckles
(Fig. 1a). However, after 2 h of CH, Daxx was detected mainly
in the cytoplasm of H9c2 cells (Fig. 1a). Daxx expression was
increased in a time-dependent manner after CH (Fig. 1b). Also
to simulate induction, H9c2 cells were incubated in serum-free,
glucose-free DMEM in an anaerobic chamber [32]. Transloca-
tion of Daxx into the cytoplasm was also observed under these
conditions (Fig. 1c). After 4 h in an anaerobic chamber, Daxx
was detected mainly in the cytoplasm. Therefore, two diﬀerent
experimental models show that, in response to ischemic injury,
Daxx is exported into the cytoplasm of H9c2 cells. Export of
Daxx from the nucleus to the cytoplasm was also observed
in L6 cells (Fig. 2d), HeLa cells (Supplemental Figs. 1 and
2), Chinese hamster lung ﬁbroblast PS120 cells (data not
shown) and neonatal primary rat cardiac myocytes (Fig. 2e).3.2. Ischemic stress induces nuclear export of some of the
PML-NB proteins
Of the known nuclear bodies [33], PML-NBs are the best
characterized [34,35]. Daxx has been reported to be a compo-
nent of PML-NBs; hence we characterized the eﬀects of ische-
mic stress on subcellular traﬃcking of the PML-NB
constituents. In resting cells, PML was detected in the nuclei
of H9c2 cells and shown to co-localize with Daxx (Fig. 2a).
p53 and SUMO1 were also co-localized with Daxx in H9c2
cells (Fig. 2b, c). Under CH conditions, PML remains in the
nucleus and has a speckle distribution, whereas Daxx,
SUMO1, and p53 are exported to the cytoplasm. In order to
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cell diﬀerentiation, neonatal primary rat cardiac myocytes and
two myoblast cell lines from embryonal heart (H9c2 cells) and
skeletal muscle (L6 cells) were selected in this study. In re-
sponse to ischemic stress, Daxx was exported to the cytoplasm
but PML was not in rat L6 myoblasts (Fig. 2d) and neonatal
primary rat cardiac myocytes (Fig. 2e). There were no signiﬁ-
cant diﬀerences in Daxx–PML association among cells of dif-
ferent developmental stages, for example, L6 (myoblast), H9c2
(cardiac myocyte), and neonatal primary rat cardiac myocytes.
In HeLa and L6 cells, not all Daxx was exported from the nu-
cleus in response to CH, demonstrating that the extent of Daxx
nuclear export diﬀers with cell type (Fig. 2d and Supplemental
Fig. 2). To further validate our confocal observations, we per-
formed immunoprecipitation with the anti-PML monoclonal
antibody 5E10 using lysates of H9c2 cells (Fig. 2f). Daxx
and p53 were detected in the precipitates of untreated cells
but not in those of CH-treated cells. These immunoprecipita-
tion data correlate well with the confocal microscopy data
regarding the redistribution of PML-NB constituents.
3.3. The nuclear presence of Daxx is essential for tethering
PML-NB constituents
Daxx can interact with SUMO1, p53, and PML [36–39];
therefore we questioned whether Daxx inﬂuences the subcellu-
lar redistribution of SUMO1, p53, and PML. An RNA inter-Fig. 3. The nuclear presence of Daxx determines the integrity of the PML-NB
rDaxx, si-rPML or si-rp53 and cell lysates were prepared after 24, 48 and 72 h
down-regulated at the indicated time points after introduction of siRNA. The
at the bottom of the panel. (b) Transfected cells were immunostained with
monoclonal antibodies. Representative immunoﬂuorescence images were obference approach was used to address this issue [40]. H9c2 cells
were transfected with rat Daxx siRNA (si-rDaxx), rat PML
siRNA (si-rPML), or rat p53 siRNA (si-rp53), as described
in Section 2. Our results indicated that siRNA eﬃciently
reduced expression of target proteins in H9c2 cells after
72 h, whereas control scrambled siRNA (scRNA) did not
(Fig. 3a). Therefore, all depletion experiments were performed
72 h after transfection.
As expected, PML-NB components were visible as distinct
nuclear speckles in scRNA transfected cells (Fig. 3b, scRNA).
Silencing of Daxx and PML caused the release of p53 and
SUMO1 from PML-NBs (Fig. 3b, middle two columns).
SUMO1 was exported from PML-NBs and a faint dispersed
pattern was visible throughout the nucleus and in the nuclear
periphery, but not in the cytoplasm. Consistent with previous
observations [10,18,25,38], depletion of PML did not aﬀect the
Daxx distribution pattern, and depletion of Daxx did not aﬀect
the PML nuclear structure (Fig. 3b and Supplemental Fig. 3).
These observations indicate that the nuclear presence of Daxx
is required for tethering PML-NB speckle constituents to-
gether. Our data show that Daxx persists as intact nuclear
speckles independently of PML and p53. However, depletion
of nuclear Daxx is as detrimental as depletion of PML in
assembling PML-NB constituents and causes dissociation of
PML-NB constituents. Collectively, our data suggest that, like
PML, Daxx might be a PML-NB scaﬀold protein.s. (a) H9c2 cells were electroporated with scrambled RNA (scRNA), si-
. Western-blot analysis of whole-cell lysates shows target proteins were
relative target protein level after normalization with b-tubulin is shown
anti-PML (5E10), rabbit anti-Daxx, rabbit anti-p53, or anti-SUMO1
tained 72 h after transfection.
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sensitivity to CH
The physiological relevance of the subcellular localization of
Daxx was studied using leptomycin B (LMB) and Daxx mu-
tants that localize to diﬀerent regions of the cell. LMB hasFig. 4. Cytoplasmic Daxx mutants promote CH-induced cell death. (a) H9c
(W621A), or pFLAG–CMV-2/Daxx (S667A). Transfected cells were stained
antibody (middle and bottom rows). Bound primary antibodies were labeled w
an FITC-conjugated anti-mouse secondary antibody (middle and bottom row
to CH for 1 h. Nuclei were visualized with PI. (b) Transfection and LMB trea
for 2 h and the pEGFP-C2 vector was used as a co-transfection marker. D
positive cells with condensed or fragmented nuclei was determined by count
panel) and HeLa cells (right panel). (c) Transfection and CH were performe
FACS analysis. The mean percentage of cell death was shown as means ± S.
cells; WB, Western blot.been shown to directly bind to CRM1 and disrupt the interac-
tion between CRM1 and the nuclear export sequence of Daxx
[15,41]. In H9c2 cells, Daxx (W621A) and Daxx (S667A)
mutants localize to the cytoplasm and nuclei, respectively
(Fig. 4a), and CH conditions did not alter the subcellular local-2 cells were transfected with pFLAG–CMV-2, pFLAG–CMV-2/Daxx
with the rabbit anti-Daxx antibody (upper row) and a mouse FLAG
ith an FITC-conjugated anti-rabbit secondary antibody (upper row) or
s). Cells were treated with LMB (20 nM) for 4 h before being subjected
tment were performed as described in (a) but cells were subjected to CH
ead cells were counted using DAPI staining. The percentage of GFP-
ing at least 300 cells from three independent experiments in H9c2 (left
d as described in (b). The percentage of dead cells was determined by
E.M. from three independent experiments. MOCK, vector-transfected
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LMB treatment prevented nuclear export of the transfected
Daxx mutants as well as endogenous Daxx, but did not to pre-
vent dispersion of Daxx to the nucleoplasm. The eﬀects of
Daxx subcellular localization on CH-induced cell death were
assessed using the DAPI assay. CH-induced cell death was also
suppressed by LMB treatment and by transfection with either
wild-type (WT) Daxx or the Daxx (S667A) mutant, but was
increased after transfection of H9c2 cells with the Daxx
(W621A) (Fig. 4b, left panel). The positive correlation between
CH-induced cell death and the presence of cytoplasmic Daxx
was further conﬁrmed in HeLa cells (Fig. 4b, right panel).
H9c2 cells were transfected with Daxx mutants and ﬂow
cytometry was used to determine the percentage of dead
GFP-gated cells (Fig. 4c). Similar protection against and sen-
sitization to CH were observed in cells transfected with Daxx
(S667A) and with Daxx (W621A), respectively.
3.5. Cytoplasmic Daxx mediates CH-induced cell death
through JNK activation
CH induces JNK activation and cell death [30]. Daxx can
mediate JNK activation in response to stresses such as UV
light, TGFb and TNFa [8,42,43]. To determine whether sub-
cellular localization of Daxx aﬀects JNK activation in response
to CH, we analyzed JNK activation in H9c2 cells. H9c2 cells
were transfected with Daxx mutants, as shown in Fig. 5. In
the absence of CH, transfection of Daxx (WT) and Daxx
(S667A) did not activate JNK (Fig. 5a). Transfection of Daxx
(WT) and Daxx (S667A) suppressed JNK activation in re-
sponse to CH when compared with MOCK transfection of
vector only. However, transfection with Daxx (W621A) wasFig. 5. JNK is required for ischemic cell death. (a) H9c2 cells were transfect
Forty-eight hours after transfection, H9c2 cells were subjected to CH for 1
assayed for kinase activity in vitro. Transfected cells were incubated with SP6
repeated at least three times and representative images are shown. To
immunoprecipitated and immunoblotted with JNK antibody; bottom row, W
cells were cotransfected with pEGFP-C2 and FLAG-conjugated Daxx cons
above. Assessment of cell death was determined from three independent expfound to activate JNK in the presence or absence of CH, indi-
cating that cytoplasmic Daxx enhances JNK activation.
Next, we examined whether, under CH conditions, inhibi-
tion of JNK signaling aﬀects the subcellular localization of
Daxx. Under CH conditions, nuclear export of endogenous
Daxx was blocked by incubation of H9c2 cells with 10 lM
SP600125, which is an inhibitor of JNK (Supplemental
Fig. 4, top row). Therefore, JNK activation seems to be re-
quired for nuclear export of Daxx. Previously, we have shown
that ASK1–SEK1–JNK1–HIPK1 signaling pathway is re-
quired for Daxx nuclear export [15]. By contrast, the subcellu-
lar localizations of Daxx (W621A) and Daxx (S667A) were not
aﬀected by SP600125 treatment (Supplemental Fig. 4, middle
and bottom rows). SP600125 did not prevent the nuclear
export of Daxx (W621A), indicating that Daxx (W621A) was
already in the correct conformation for nuclear export [15].
The ﬁnding that SP600125 administration did not induce cell
death in Daxx (W621A)-transfected cells indicates that the
presence of Daxx in the cytoplasm is not suﬃcient to cause cell
death. By contrast, inhibition of JNK activation prevented
ischemic cell death regardless of the subcellular localizations
of Daxx in H9c2 cells (Fig. 5b). Together, these data indicate
that JNK plays an essential role in ischemic cell death via cyto-
plasmic Daxx, and it is likely that cytoplasmic Daxx activates
JNK by ASK1 oligomerization [14,15].
3.6. Daxx depletion induces JNK activation and p53 activation
We next analyzed the silencing eﬀect of Daxx. JNK activa-
tion was enhanced in si-rDaxx-transfected cells regardless of
CH (Fig. 6a). Recent studies have revealed that Ras-associated
domain family 1C protein (RASSF1C) activates JNK in theed with 2 lg plasmid DNA cloned into pFLAG–CMV-2 as indicated.
h, and cell lysates were immunoprecipitated with JNK antibody and
00125 (10 lM) for 30 min before and during CH. The experiments were
p row, phosphorylation of GST-c-Jun; middle row, WCLs were
CLs were immunoblotted with FLAG antibody. (b) H9c2 and HeLa
tructs. Dead cells were counted by DAPI staining assay as described
eriments in H9c2 (left panel) and HeLa cells (right panel).
Fig. 6. Daxx depletion activates JNK and p53-mediated transcrip-
tional activity. (a) H9c2 cells were transfected with 2 lg of each RNA
oligonucleotide as indicated. Seventy-two hours after transfection, CH
was applied to H9c2 cells for 1 h and an in vitro kinase assay was
performed. (b) The pG13-luc was transfected with diﬀerent combina-
tions as indicated into H9c2 cells. Luciferase assays were performed
72 h after transfection. (c) H9c2 cells were transiently cotransfected
with pEGFP-C2 and RNA oligonucleotides (scRNA, si-rDaxx, si-rp53
and si-rPML). After 72 h of transfection, 2 h of CH was applied or not
and the percentages of cell death were calculated using DAPI staining.
Ctrl, untransfected cells.
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PML-NB and inhibits JNK activation, Daxx depletion would
release RASSF1C to the cytoplasm. Therefore, JNK activation
upon Daxx depletion under our experimental condition is not
an unexpected consequence.
Previous studies have shown that Daxx acts as a negative
regulator of p53 [39,45]. Therefore, we examined whetherDaxx aﬀects p53-mediated transcription. As shown in
Fig. 6b, cells transfected with si-rDaxx enhanced p53-mediated
transcription. And Daxx depletion increased cell death signif-
icantly; cell deaths were 23.7 ± 1.3% for scRNA and
36.3 ± 2.1% for si-rDaxx, respectively, upon induction of CH
when determined by DAPI analysis (Fig. 6c). p53 depletion
and PML depletion, respectively, protected cells from CH-in-
duced cell death. Our data were consistent with previous stud-
ies showing the protective eﬀect of p53 depletion [46–48].
Collectively, these data might suggest that Daxx depletion sen-
sitizes H9c2 cells to CH via JNK activation and p53 activation.4. Discussion
We have studied Daxx function in ischemic stress and,
through the use of localization-speciﬁc Daxx mutants, shown
that Daxx has multiple functions depending on its subcellular
distribution. Nuclear Daxx in PML-NBs is required for tether-
ing the constituents of PML-NBs, as well as protecting H9c2
cells from ischemic death. Cytoplasmic Daxx promotes cell
death through JNK activation. Collectively, this study shows
that Daxx has diﬀerent eﬀects in CH-induced cell death
according to its subcellular localization.
Among the nuclear speckles reported to date, PML-NB is
the best characterized and more than 30 proteins have been re-
ported to localize to PML-NBs [12,49,50]. To date, PML has
been the focus of studies on PML-NB structure, as it is an
important scaﬀold component. However, the present study
provides evidence that Daxx is also essential for PML-NB
integrity. This requirement for Daxx was validated by Daxx
depletion experiments, which showed that Daxx depletion in-
duced dissociation of PML-NB constituents as eﬀectively as
PML depletion. Moreover, PML depletion failed to disrupt
Daxx speckles, indicating that Daxx localization is indepen-
dent of PML localization, which is contrary to the previous re-
ports [38,51]. Based on the fact that both Daxx and PML are
required for localization of p53 and SUMO1 to PML-NBs, it
is possible that Daxx and PML cooperate in maintaining
PML-NB integrity.
Our data show that JNK activation plays an important role
in ischemia-induced cell death in H9c2 cells. Considering that
Daxx facilitates ASK1 oligomerization, the increase in JNK
activation by cytoplasmic Daxx is not surprising. However,
suppression of improper JNK activation in resting cells seems
to be an equally important function of Daxx. RASSF1C is
associated with Daxx in PML-NBs in resting cells. If Daxx dis-
appears from PML-NBs, RASSF1C is released from the nu-
cleus and activates JNK [44]. Therefore, sequestration of
RASSF1C by Daxx to the PML-NBs would prevent erroneous
JNK activation. It is interesting that nuclear Daxx suppresses
JNK activation, whereas cytoplasmic Daxx promotes JNK
activation.
Blocking JNK activation prevented Daxx nuclear export.
And blocking Daxx nuclear export inhibited JNK activation.
Our results show the presence of reciprocal regulation between
nuclear export of Daxx and JNK activation suggesting the
presence of a positive feedback loop.
In summary, the results of the present study demonstrate
protection against ischemic cell death by nuclear Daxx.
Nuclear Daxx seems to prevent improper activation of JNK
Y.-S. Jung et al. / FEBS Letters 581 (2007) 843–852 851in resting cells. It is tempting to speculate that nuclear Daxx
may sequester other potentially death-promoting proteins in
addition to p53 and RASSF1C to PML-NBs. Identiﬁcation
of additional constituents of the PML-NBs would facilitate
our understanding of these protective mechanisms. Consider-
ing the reduction in ischemia-induced cell mortality when
Daxx export to the cytoplasm is blocked, antagonistic com-
pounds that block Daxx traﬃcking could potentially serve as
therapeutic agents for the treatment of ischemic diseases.
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